Literature DB >> 8998148

Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial.

Z X He1, A S Iskandrian, N C Gupta, M S Verani.   

Abstract

UNLABELLED: Exercise 99mTc-tetrofosmin myocardial scintigraphy is as accurate as exercise 201TI imaging. Thus far, no data are available on tetrofosmin imaging during pharmacologic stress. We evaluated the feasibility of using. 99mTc-tetrofosmin myocardial SPECT during vasodilation with dipyridamole for detecting coronary artery disease.
METHODS: Sixty-four patients, enrolled in three centers in the U.S., underwent one-day dipyridamole/rest tetrofosmin SPECT. Coronary angiography, performed in 59 patients within 2 mo of the SPECT study, revealed normal coronary arteries or insignificant coronary stenosis in 11 patients and significant (> or = 50% luminal diameter stenosis) coronary stenoses in 48 patients.
RESULTS: Sensitivity and specificity of tetrofosmin SPECT for detecting coronary artery disease were 85% and 55%, respectively, in the overall population and 81% and 55% in patients without prior coronary artery bypass surgery. The overall sensitivity and specificity of tetrofosmin tomographic imaging for detection of individual coronary stenoses were 53% and 72%, respectively, in the overall population and 54% and 80% in the patients without prior coronary artery bypass surgery.
CONCLUSION: One-day dipyridamole/rest 99mTc-tetrofosmin myocardial perfusion imaging is feasible and has a high sensitivity for detection of coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8998148

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  Evaluation of left ventricular wall motion, volumes, and ejection fraction by gated myocardial tomography with technetium 99m-labeled tetrofosmin: a comparison with cine magnetic resonance imaging.

Authors:  P Vaduganathan; Z X He; G W Vick; J J Mahmarian; M S Verani
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 2.  Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging.

Authors:  C Y Loong; C Anagnostopoulos
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

3.  Regarding the virtues and limitations of combining myocardial perfusion SPECT data acquired by diverse methods.

Authors:  Kenneth J Nichols
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

4.  Diagnostic accuracy of high-resolution attenuation-corrected Anger-camera SPECT in the detection of coronary artery disease.

Authors:  Harshal R Patil; Timothy M Bateman; A Iain McGhie; Eric V Burgett; Staci A Courter; James A Case; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-11-21       Impact factor: 5.952

5.  Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used?

Authors:  Z X He; M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

6.  A comparison of Tl-201, Tc-99m sestamibi, and Tc-99m tetrofosmin myocardial perfusion scintigraphy in patients with mild to moderate coronary stenosis.

Authors:  Eliana Reyes; Chee Y Loong; Mark Harbinson; Shelley Rahman; Elizabeth Prvulovich; Peter J Ell; Constantinos Anagnostopoulos; S Richard Underwood
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

7.  Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity.

Authors:  A Elhendy; F B Sozzi; R Valkema; R T van Domburg; J J Bax; J R Roelandt
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

8.  Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging.

Authors:  M G Levine; A W Ahlberg; A Mann; M P White; C C McGill; C Mendes de Leon; J M Piriz; D Waters; G V Heller
Journal:  J Nucl Cardiol       Date:  1999 Jul-Aug       Impact factor: 5.952

9.  Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial).

Authors:  Juerg Schwitter; Christian M Wacker; Norbert Wilke; Nidal Al-Saadi; Ekkehart Sauer; Kalman Huettle; Stefan O Schönberg; Kurt Debl; Oliver Strohm; Hakan Ahlstrom; Thorsten Dill; Nadja Hoebel; Tamas Simor
Journal:  J Cardiovasc Magn Reson       Date:  2012-09-02       Impact factor: 5.364

10.  Comparison of ⁹⁹mTc-N-DBODC5 and ⁹⁹mTc-MIBI of myocardial perfusion imaging for diagnosis of coronary artery disease.

Authors:  Haiyan Ma; Sijin Li; Zhifang Wu; Jianzhong Liu; Haiyan Liu; Xiaoshan Guo
Journal:  Biomed Res Int       Date:  2013-06-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.